Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research for Patient Benefit Programme London Competition 51 Stage 2 and Competition 52 Stage 1 Minutes

Contents

Published: 18 March 2024

Version: 1.0 March

Print this document

Minutes for the Research for Patient Benefit (RfPB) programme London Regional Advisory Committee meeting to discuss Stage 2 applications to Competition 51 and Stage 1 applications to Competition 52.

Date and Location

Wednesday 24 January 2024 at etc.venues Marble Arch, 86 Edgware Rd, London W2 2EA, UK

In attendance

  • Professor Chris Gale (Chair)
  • Dr Thomas Booth
  • Miss Eva Broeckelmann
  • Professor Kate Brown
  • Dr Julia Chisholm
  • Professor Francesco D'Aiuto
  • Dr Anna De Simoni
  • Ms Eva Driskell
  • Mr Thomas Hamborg
  • Mrs Mary Harvey
  • Professor Angela Hassiotis
  • Dr Philip Kinghorn
  • Professor Matthew Maddocks
  • Dr Mariana Pinto Da Costa
  • Mr Alan Quarterman
  • Dr Clare Robinson  - starts Jan 24
  • Dr Amanda Sathyapala
  • Dr Katie Sheehan
  • Dr Susan Shelmerdine
  • Dr Cristina Fernandez Turienzo
  • Professor Charlotte Warren-Gash
  • Dr Dominik Zenner
  • Dr Amanda Sathyapala

Secretariat

  • Mr Richard Foulsham (NIHRCC)
  • Dr Ianina Conte (NIHRCC)
  • Ms Annika Phillips (NIHRCC)
  • Ms Lavpreet Ranjit (NIHRCC)

Observers

  • Ms Jess Nye- NIHR SCPR
  • Dr Balasundaram Kadirvelu- RSS London

Competition 51 Stage 2 applications considered

NIHR206676: Tackling the Repercussions of UK-based Stigma towards Tuberculosis (TRUST): a participatory study to co-design a stigma reduction intervention
Conflicts: None

Final outcome: Conditional support

NIHR206589: Medication brand changes in hormone therapy for breast cancer. A community pharmacy intervention development to improve patients’ adherence and quality of life. ENABLE
Conflicts: None

Final outcome: Conditional support

NIHR206680: To validate remote digital image-based surgical wound monitoring as a method for clinicians to diagnose surgical site infections (DIAMOND)
Conflicts: None

Final outcome: Reject

NIHR206718: PlatEleT-rich plasma and Autologous lipotransfer to treat vulval fibrosis in Lichen Sclerosus – the PETALS multicentre randomised controlled feasibility trial
Conflicts: None

Final outcome: Conditional support

NIHR206696: Developing and refining a virtual reality intervention that will help to manage pain for people living with advanced cancer
Conflicts: None

Final outcome: Conditional support

NIHR206684: Developing a perinatal mental health peer support intervention to address the needs of women with experience of intimate partner violence (IPV): a qualitative study
Conflicts: Professor Chris Gale

Final outcome: Conditional support

NIHR206694: Exploring the impact of endocrine therapy brand switching in patients with breast cancer (SWITCH)
Conflicts: None

Final outcome: Conditional support

Competition 52 Stage 1 applications considered

NIHR207172: Medicines prescribed in pregnancy: assessing safety for mother and baby using routine NHS data
Conflicts: Dr Clare Robinson

Outcome: Invite to Stage 2

NIHR207217: The feasibility and acceptability of cognitive behavioural therapy for fear of death: a randomised controlled trial
Conflicts: Miss Eva Broeckelmann

Outcome: Reject

NIHR207222: Using a community network and a whole systems data approach to monitor the changing health care burden of childhood bronchiolitis and influence RSV vaccine acceptability in North-West London: a mixed methods study
Conflicts: Dr Clare Robinson, Professor Chris Gale, Professor Kate Brown

Outcome: Invite to Stage 2

NIHR207236: Impact of at-home subcutaneous furosemide in heart failure patients with chronic kidney disease on prevention of hospital admission; a randomised controlled, feasibility trial
Conflicts: None

Outcome: Invite to Stage 2

NIHR207178: Development of a Sexual Function Patient Reported Outcome Measure (sex-PROM) for patients undergoing benign pelvic colorectal surgery
Conflicts: Mr Thomas Hamborg

Outcome: Reject

NIHR207208: Enhancing Cancer Care Efficiency and Patient Benefit: An Effectiveness-Implementation Study of a Streamlined Workload Strategy proposed by NHS England
Conflicts: Dr Thomas Booth

Outcome: Reject

NIHR207215: Improving hormonal treatment for men with infertility due to hypogonadotropic hypogonadism.
Conflicts:None

Outcome: Invite to Stage 2

NIHR207216: Investigating the time-course and severity of withdrawal symptoms when men try stopping anabolic steroids.
Conflicts: None

Outcome: Reject

NIHR207152: Developing Interventions to Tackle Ethnicity-based Disparities in Asthma Management in British South Asians (The TEAMS study)
Conflicts: Dr Philip Kinghorn

Outcome: Invite to Stage 2

NIHR207159: Feasibility and Acceptability of Screening for Behavioural and Psychological Symptoms in Primary Care to Improve Dementia Risk Determination
Conflicts: None

Outcome: Reject

NIHR207143: A mixed methods realist evaluation into the Maternal Early Childhood Sustained Home visiting (MECSH) programme delivered by health visitors to vulnerable families in England
Conflicts: None

Outcome: Reject

NIHR207168: Safety and Effects of Moderate Exercise in Patients with Cardiomyopathies
Conflicts: Professor Angela Hassiotis, Dr Amanda Sathyapala

Outcome: Reject

Outcomes Table

The tables below display the mean scores for each application that was assessed in the regional assessment committee meeting. They exclude applications that were rejected during the scrutiny and triage processes. 

The number of applications receiving each mean score is listed. The fundable range is 4-6 although a score of 4-6 does not guarantee funding or an invitation to Stage 2. 

In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.  

Stage 2

ScoreNumber of Applications FundedNumber of Applications Rejected
5.0-6.0 1 0
4.0-4.9 5 0
3.0-3.9 0 1
2.0-2.9 0 0
1.0-1.9 0 0

Stage 1

ScoreNumber of Applications InvitedNumber of Applications Rejected
5.0-6.0 0 0
4.0-4.9 4 0
3.0-3.9 1 0
2.0-2.9 0 7
1.0-1.9 0 0